Analgesics and Anti-inflammatory Drugs Practice Questions

Q: What is the recommended dose of methotrexate for the treatment of rheumatoid arthritis?

7.5 - 15 mg per week. **Explanation:** Methotrexate (MTX) is the "anchor drug" and the first-line Disease-Modifying Antirheumatic Drug (DMARD) for Rheumatoid Arthritis (RA). In RA, it acts primarily by inhibiting **aminoimidazolecarboxamide ribonucleotide (AICAR) transformylase**, leading to increased extracellular adenosine, which has potent anti-inflammatory effects. **Why Option A is Correct:** The standard starting dose for RA is **7.5 to 15 mg administered once weekly**. This dose is significantly lower than those used in cancer chemotherapy because the goal is immunomodulation rather than cytotoxicity. The dose can be escalated up to 25 mg/week based on patient response and tolerance. **Why Other Options are Incorrect:** * **Options B & D (2.5 - 5 mg):** These doses are sub-therapeutic for RA and would fail to achieve adequate disease control. * **Options C & D (Monthly dosing):** Methotrexate has a relatively short half-life; monthly administration would not maintain the steady-state concentration required to suppress chronic synovial inflammation. **Weekly dosing** is the gold standard to balance efficacy with safety. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism (Low dose):** Increases adenosine (anti-inflammatory). * **Mechanism (High dose/Onco):** Inhibits **Dihydrofolate Reductase (DHFR)**, preventing DNA synthesis. * **Supplementation:** Always co-prescribe **Folic acid (5 mg)** to reduce GI side effects, mucosal ulcers, and hepatotoxicity without compromising efficacy. * **Monitoring:** Regular Liver Function Tests (LFTs) and CBC are mandatory due to risks of hepatotoxicity and bone marrow suppression. * **Contraindication:** It is highly **teratogenic** (Category X); it must be stopped at least 3 months before conception in both males and females.

Q: Which drug possesses both analgesic and moderate anti-inflammatory properties?

Ketorolac. **Explanation:** **Ketorolac** is a potent NSAID primarily used for its superior analgesic efficacy, often compared to morphine for postoperative pain. Unlike most other potent analgesics (like opioids), it also possesses **moderate anti-inflammatory** activity. It acts by non-selectively inhibiting COX-1 and COX-2 enzymes, thereby decreasing prostaglandin synthesis. In clinical practice, it is favored for short-term management of acute severe pain where an anti-inflammatory component is also beneficial. **Analysis of Incorrect Options:** * **A. Paracetamol (Acetaminophen):** While a first-line analgesic and antipyretic, it has **negligible anti-inflammatory** activity because it is inactivated by peroxides at sites of inflammation. * **B. Nimesulide:** This is a preferential COX-2 inhibitor. While it has anti-inflammatory properties, it is primarily classified as an anti-inflammatory drug with analgesic effects, rather than being the specific answer for "moderate" anti-inflammatory activity in this comparative context. * **D. Diflunisal:** A salicylic acid derivative. While it has a long half-life and anti-inflammatory properties, its analgesic potency is significantly lower than that of Ketorolac. **High-Yield NEET-PG Pearls:** * **Ketorolac** should not be used for more than **5 days** due to the high risk of gastrointestinal mucosal lesions and renal toxicity. * It is the most common NSAID used **parenterally** (IV/IM) for post-operative analgesia. * **Topical Ketorolac** is frequently used in ophthalmology to prevent miosis during ocular surgery and to treat seasonal allergic conjunctivitis.

Q: Which of the following medications can be safely administered to a patient with congestive heart failure?

Paracetamol. **Explanation:** The correct answer is **Paracetamol (Acetaminophen)**. **Why Paracetamol is the correct choice:** In patients with Congestive Heart Failure (CHF), maintaining optimal renal perfusion and fluid balance is critical. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) inhibit the enzyme Cyclooxygenase (COX), which leads to a decrease in the synthesis of vasodilatory prostaglandins (PGE2 and PGI2). In CHF, these prostaglandins are essential to counteract the vasoconstrictive effects of the Renin-Angiotensin-Aldosterone System (RAAS). **Paracetamol** is a weak peripheral prostaglandin inhibitor and primarily acts centrally. Therefore, it does not interfere with renal blood flow, does not cause sodium/water retention, and does not exacerbate heart failure, making it the safest analgesic for these patients. **Why the other options are incorrect:** * **Aspirin, Diclofenac, and Ibuprofen:** These are traditional NSAIDs. By inhibiting renal prostaglandins, they cause afferent arteriolar vasoconstriction, leading to decreased glomerular filtration rate (GFR). This results in **sodium and water retention**, which increases preload and afterload, potentially triggering an acute decompensation of heart failure. * Furthermore, NSAIDs can blunt the efficacy of life-saving CHF medications like ACE inhibitors and Diuretics. **Clinical Pearls for NEET-PG:** * **NSAIDs and CHF:** The risk of heart failure hospitalization doubles with the use of NSAIDs. * **Cardiovascular Risk:** Among NSAIDs, **Naproxen** is considered to have the safest cardiovascular profile, while **Diclofenac** and **Selective COX-2 inhibitors (Coxibs)** carry the highest risk of thrombotic events (MI/Stroke). * **Drug of Choice:** Paracetamol remains the first-line analgesic for patients with cardiovascular comorbidities.

Q: Nausea and vomiting associated with the administration of opioid analgesics are the result of stimulation of which of the following?

Chemoreceptor trigger zone (CTZ). ### Explanation **Correct Option: C. Chemoreceptor Trigger Zone (CTZ)** Opioid-induced nausea and vomiting (OINV) primarily occur due to the direct stimulation of **mu (μ) and kappa (κ) receptors** located in the **Chemoreceptor Trigger Zone (CTZ)**. The CTZ is situated in the **area postrema** on the floor of the fourth ventricle. Because this area lies outside the blood-brain barrier, it can be directly stimulated by circulating drugs like morphine. Additionally, opioids increase the sensitivity of the vestibular apparatus, which further contributes to motion-induced nausea. **Analysis of Incorrect Options:** * **A. Limbic system:** While the limbic system is involved in the emotional and affective components of pain and reward (addiction), it is not the primary center for triggering the emetic reflex. * **B. Emetic system:** The "emetic center" (Vomiting Center) in the medulla coordinates the physical act of vomiting. While the CTZ sends signals to the emetic center, opioids act initially on the CTZ to trigger this pathway, rather than stimulating the emetic center directly. * **D. Opioid receptors in the GI tract:** Stimulation of peripheral mu-receptors in the gastrointestinal tract leads to **decreased motility and constipation** (Opioid-induced constipation), not nausea and vomiting. **High-Yield Clinical Pearls for NEET-PG:** * **Tolerance:** While patients develop tolerance to the emetic effects of opioids over time, they **never** develop tolerance to **miosis (pin-point pupil)** and **constipation**. * **Management:** Opioid-induced vomiting can be managed with dopamine antagonists (e.g., Metoclopramide) or 5-HT3 antagonists (e.g., Ondansetron). * **Dual Mechanism:** Opioids have a "biphase" effect; at low doses, they stimulate the CTZ (emetic), but at very high doses, they may actually depress the vomiting center.

Q: Which of the following drugs inhibits de novo synthesis of purines?

Mycophenolate. **Explanation:** **Correct Answer: C. Mycophenolate** Mycophenolate mofetil (MMF) is a potent, reversible inhibitor of the enzyme **Inosine Monophosphate Dehydrogenase (IMPDH)**. This enzyme is the rate-limiting step in the **de novo synthesis of guanosine nucleotides (purines)**. While most cells can use the "salvage pathway" to produce purines, T and B lymphocytes are uniquely dependent on the de novo pathway for proliferation. By inhibiting this synthesis, Mycophenolate exerts a selective cytostatic effect on lymphocytes, making it a cornerstone in transplant medicine and autoimmune therapy. **Analysis of Incorrect Options:** * **A & B (Cyclosporine and Tacrolimus):** These are **Calcineurin Inhibitors**. They work by binding to intracellular proteins (Cyclophilin and FKBP-12, respectively) to inhibit calcineurin, thereby preventing the dephosphorylation of NFAT (Nuclear Factor of Activated T-cells). This inhibits the transcription of **Interleukin-2 (IL-2)**, rather than affecting purine synthesis. * **D (Infliximab):** This is a chimeric monoclonal antibody that acts as a **TNF-α (Tumor Necrosis Factor) inhibitor**. It neutralizes the biological activity of TNF-α by binding to its soluble and transmembrane forms, used primarily in Crohn’s disease and Rheumatoid Arthritis. **High-Yield NEET-PG Pearls:** * **Selectivity:** Mycophenolate is preferred over Azathioprine in many regimens because of its higher lymphocyte selectivity and lower incidence of bone marrow suppression. * **Side Effects:** The most common dose-limiting side effects of Mycophenolate are **GI distress** (nausea, diarrhea) and hematological (leukopenia). * **Teratogenicity:** It is associated with "Mycophenolate embryopathy" (ear and facial malformations), making it contraindicated in pregnancy. * **Drug Interaction:** Unlike Azathioprine, Mycophenolate metabolism is **not** affected by Allopurinol.

Q: Muscle rigidity caused by fentanyl is primarily due to its action on which opioid receptor?

Mu (μ). **Explanation:** **Muscle rigidity** (specifically "Wooden Chest Syndrome") is a well-known side effect of rapid, high-dose intravenous administration of potent synthetic opioids like **fentanyl**, sufentanil, and remifentanil. 1. **Why Mu (μ) is correct:** The mechanism is primarily mediated by **Mu-opioid receptors** located in the **striatum** (basal ganglia) and the **substantia nigra**. Activation of these receptors inhibits GABAergic neurons, leading to a decrease in GABA release. This results in the disinhibition of central dopaminergic pathways, causing increased motor outflow and intense skeletal muscle contraction, particularly in the thoracic and abdominal muscles. This rigidity can make bag-mask ventilation nearly impossible. 2. **Why other options are incorrect:** * **Kappa (κ):** These receptors are primarily associated with spinal analgesia, sedation, and dysphoria/hallucinations. They do not play a significant role in opioid-induced muscle rigidity. * **Delta (δ):** These receptors contribute to supraspinal/spinal analgesia and modulation of Mu-receptor activity but are not the primary mediators of motor rigidity. * **Sigma (σ):** Formerly classified as an opioid receptor, it is now considered a non-opioid receptor. It is associated with antitussive effects and psychotomimetic effects (like those seen with ketamine), not muscle rigidity. **Clinical Pearls for NEET-PG:** * **Management:** The definitive treatment for fentanyl-induced chest wall rigidity is the administration of a **muscle relaxant** (e.g., Succinylcholine) and endotracheal intubation. Opioid antagonists like **Naloxone** can reverse it but will also abolish analgesia. * **Prevention:** Administer fentanyl slowly and in lower doses. * **High-Yield Fact:** Rigidity is most common with **lipophilic** opioids that rapidly cross the blood-brain barrier.

Q: Morphine is used in the treatment of which of the following conditions?

Acute left ventricular failure. **Explanation:** Morphine is a cornerstone in the management of **Acute Left Ventricular Failure (LVF)** and Acute Pulmonary Edema. Its therapeutic benefit is derived from its unique hemodynamic and central effects: 1. **Venodilation:** Morphine increases venous capacitance (peripheral pooling of blood), which reduces **preload**. This decreases the workload on the failing left ventricle. 2. **Arteriodilation:** It causes mild arterial dilation, reducing **afterload** and improving cardiac output. 3. **Anxiolysis:** By relieving the intense anxiety and "air hunger" (dyspnea) associated with pulmonary edema, it reduces sympathetic overactivity, further lowering myocardial oxygen demand. **Analysis of Incorrect Options:** * **A. Hypertension:** Morphine is not an antihypertensive. While it may cause a transient drop in BP due to histamine release and vasodilation, it is never used to treat chronic or acute hypertension. * **B. Cardiac Arrhythmias:** Morphine has no anti-arrhythmic properties. In fact, it can occasionally trigger bradycardia via vagal stimulation. * **D. A-V Block:** Morphine increases vagal tone, which can potentially worsen an atrioventricular (A-V) block. Atropine is the drug of choice for symptomatic bradycardia/A-V blocks. **NEET-PG High-Yield Pearls:** * **Mnemonic for LVF Management:** **LMNOP** (L-Loop diuretics, M-Morphine, N-Nitrates, O-Oxygen, P-Positioning/Pressors). * **Specific Antidote:** Naloxone is the competitive antagonist used for morphine overdose. * **Contraindications:** Avoid morphine in Head Injury (masks pupillary signs, increases ICP), Bronchial Asthma (histamine release), and Biliary Colic (causes spasm of the Sphincter of Oddi).

Question 1

What is the recommended dose of methotrexate for the treatment of rheumatoid arthritis?

Accepted Answer

7.5 - 15 mg per week

Answer

2.5 - 5 mg per week

Answer

7.5 - 15 mg per month

Answer

2.5 - 5 mg per month

Question 2

Which drug possesses both analgesic and moderate anti-inflammatory properties?

Accepted Answer

Ketorolac

Answer

Paracetamol

Answer

Nimesulide

Answer

Diflunisal

Question 3

Which of the following medications can be safely administered to a patient with congestive heart failure?

Accepted Answer

Paracetamol

Answer

Aspirin

Answer

Diclofenac sodium

Answer

Ibuprofen

Question 4

Nausea and vomiting associated with the administration of opioid analgesics are the result of stimulation of which of the following?

Accepted Answer

Chemoreceptor trigger zone (CTZ)

Answer

Limbic system

Answer

Emetic system

Answer

Opioid receptors in the gastrointestinal tract

Question 5

Cyclosporine acts on which of the following lymphocyte subsets?

Accepted Answer

CD4 cells

Answer

CD8 cells

Answer

B-Lymphocytes

Answer

T-Lymphocytes

Question 6

Which of the following drugs inhibits de novo synthesis of purines?

Accepted Answer

Mycophenolate

Answer

Cyclosporine

Answer

Tacrolimus

Answer

Infliximab

Question 7

Less gastrointestinal bleed is seen in the following NSAID.

Accepted Answer

COX2 specific inhibitors

Answer

Meloxicam

Answer

Naproxen

Answer

Ibuprofen

Question 8

What is the DOC for acute attack of Hereditary angioneurotic edema?

Accepted Answer

C1 inhibitor concentrate

Answer

Danazol

Answer

Icatibant

Answer

Methylprednisolone

Question 9

Muscle rigidity caused by fentanyl is primarily due to its action on which opioid receptor?

Accepted Answer

Mu (μ)

Answer

Kappa (κ)

Answer

Delta (δ)

Answer

Sigma (σ)

Question 10

Morphine is used in the treatment of which of the following conditions?

Accepted Answer

Acute left ventricular failure

Answer

Hypertension

Answer

Cardiac arrhythmias

Answer

A-V block

Analgesics and Anti-inflammatory Drugs — MCQs

Analgesics and Anti-inflammatory Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?